Acetylsalicylic acid Not Yet Recruiting Phase 2 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Deficiency, Vitamin D / Disseminated Intravascular Coagulation (DIC) / COVID / Coagulation Disorders Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04363840The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations